Federal Register Proposed rule: FDA is extending to 8/4 the comment period for an 11/8/07 proposed rule in the Federal Register that would establish regulations for blood and blood components, including source plasma and source leukocytes, to add donor requirements that are consistent with current practices in the blood industry, and to more closely align the regulations with current FDA recommendations. To view this proposed rule, click here.